Related Experiment Videos
Colonic epithelium reactive monoclonal antibodies. Identification and immunohistochemical localization of the target
C P Verstijnen1, J W Arends, P T Moerkerk
1Department of Pathology, State University of Limburg, Maastricht, The Netherlands.
Abstract:
We have produced a small library of colonic mucosa and colorectal carcinoma reactive monoclonal antibodies (MoAbs) by immunizations with extracts of human colon cancer tissue and a human colon cancer cell line. Hybridoma supernatants were tested on (normal and neoplastic) human tissues by immunoperoxidase methods to evaluate organ or tissue specificity. Initial biochemical characterization of the target antigens was performed by gelpermeation chromatography, Western blotting and competition assays. Based upon the immunoreactivity patterns and the characteristics of the antigen four groups of MoAbs could be distinguished. The first group concerns the antibodies PARLAM 3, 9 and 10. These antibodies react with an 87 kDa protein moiety in high molecular weight (2-5 x 10(6) Da) glycoproteins. In intestinal and colon mucosa these antibodies showed diffuse binding with goblet cells. In colon carcinoma decreased reactivity with these MoAbs was found. The second group consists of antibodies PARLAM 8, 12 and 13. These antibodies react with large (greater than 5 x 10(6) Da) glycoproteins, most likely with carbohydrate epitopes. By immunohistochemistry in normal colon mucosa the antibodies all show granular supranuclear reactivity with goblet cells. These antibodies show increased reactivity with colon adenomas and adenocarcinomas. A third group is formed by PARLAM 2, which also reacts with a large (greater than 5 x 10(6) Da) glycoprotein, showing a granular distribution in goblet cells. In colon carcinomas more extensive expression is found than in normal colonic mucosa. Finally, the fourth group consists of PARLAM 11, which also reacts with a large (greater than 5 x 10(6) Da) glycoprotein, located in the brush border of colonic columnar cells. These antibodies might be useful tools for the analysis of the expression of mucin related glycoproteins in normal, preneoplastic and neoplastic colon mucosa.
Insights
Researchers developed monoclonal antibodies (MoAbs) targeting colon cancer tissues. These antibodies show varying reactivity with normal and cancerous colon cells, aiding in the analysis of glycoproteins in colorectal neoplasia.
Area of Science:
- Oncology
- Immunology
- Biochemistry
Background:
- Colorectal cancer (CRC) diagnosis and understanding rely on identifying specific biomarkers.
- Monoclonal antibodies (MoAbs) offer high specificity for antigen detection in tissues.
Purpose of the Study:
- To generate and characterize a library of MoAbs reactive with human colonic mucosa and colorectal carcinoma.
- To evaluate the specificity and target antigens of these MoAbs for potential diagnostic applications.
Main Methods:
- Immunization of mice with human colon cancer extracts and cell lines.
- Screening of hybridoma supernatants using immunoperoxidase staining on normal and neoplastic human tissues.
- Biochemical characterization of antigens via gel permeation chromatography, Western blotting, and competition assays.
Main Results:
- Four distinct groups of MoAbs were identified based on antigen characteristics and reactivity patterns.
- Group 1 (PARLAM 3, 9, 10) targets an 87 kDa protein in high molecular weight glycoproteins, showing decreased reactivity in colon carcinoma.
- Group 2 (PARLAM 8, 12, 13) and Group 3 (PARLAM 2) target large glycoproteins (carbohydrate epitopes), with increased reactivity in adenomas and adenocarcinomas.
- Group 4 (PARLAM 11) targets a large glycoprotein in the brush border of colonic columnar cells.
Conclusions:
- The developed MoAbs exhibit differential reactivity with normal, preneoplastic, and neoplastic colonic tissues.
- These MoAbs are potential tools for analyzing mucin-related glycoproteins in the context of colorectal cancer progression.